Living Cell Technologies Limited

LVCLYOTCHealthcare

$0.03

+$0.01(+24.39%)

Market Cap$11392472

P/E Ratio—

52W High$0.08

52W Low$0.02

Avg Volume908

Open$0.03

Beta0.76

Earnings Financials Revenue

Living Cell Technologies Limited (LVCLY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LVCLY · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2024Report Date: Apr 29, 2024

EPS Actual

-$0.00

Revenue

—

Fiscal Period

Q2 FY2024

FY ends December

Report Date

Apr 29, 2024

After Market Close

LVCLY reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2024	Apr 29, 2024	—	-$0.00	—	—	—	—
— Q2 FY2023	Jun 30, 2023	—	-$0.00	—	$0.00B	—	—
— Q4 FY2022	Dec 31, 2022	—	-$0.00	—	—	—	—
— Q2 FY2022	Jun 30, 2022	—	-$0.00	—	$0.00B	—	—
— Q4 FY2021	Dec 31, 2021	—	-$0.00	—	—	—	—
— Q2 FY2021	Jun 30, 2021	—	-$0.00	—	$0.00B	—	—
— Q4 FY2020	Dec 31, 2020	—	-$0.00	—	$0.00B	—	—
— Q2 FY2020	Jun 30, 2020	—	-$0.00	—	$0.00B	—	—

Q2 FY2024

Apr 29, 2024

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2023

Jun 30, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2022

Dec 31, 2022

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2022

Jun 30, 2022

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2021

Dec 31, 2021

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2021

Jun 30, 2021

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2020

Dec 31, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2020

Jun 30, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for LVCLY.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2024	Apr 29, 2024	—	$0.04	—	—
— Q2 FY2023	Jun 30, 2023	—	$0.07	$0.07	+2.79%
— Q4 FY2022	Dec 31, 2022	—	$0.07	$0.05	-31.03%
— Q2 FY2022	Jun 30, 2022	—	$0.03	$0.03	+0.00%
— Q4 FY2021	Dec 31, 2021	—	$0.03	$0.03	+0.00%
— Q2 FY2021	Jun 30, 2021	—	$0.09	$0.09	+0.00%
— Q4 FY2020	Dec 31, 2020	—	$0.10	$0.06	-43.60%
— Q2 FY2020	Jun 30, 2020	—	$0.08	$0.08	+0.00%

Q2 FY2024—

Report Date

Apr 29, 2024

EPS Beat/Miss

—

Price Before

$0.04

Price After

—

Q2 FY2023+2.79%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.07

Price After

$0.07

Q4 FY2022-31.03%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$0.07

Price After

$0.05

Q2 FY2022+0.00%

Report Date

Jun 30, 2022

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q4 FY2021+0.00%

Report Date

Dec 31, 2021

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q2 FY2021+0.00%

Report Date

Jun 30, 2021

EPS Beat/Miss

—

Price Before

$0.09

Price After

$0.09

Q4 FY2020-43.60%

Report Date

Dec 31, 2020

EPS Beat/Miss

—

Price Before

$0.10

Price After

$0.06

Q2 FY2020+0.00%

Report Date

Jun 30, 2020

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.08

Beat Rate0 / 8 quarters

Largest Move-43.60% (Q4 FY2020)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Living Cell Technologies Limited (LVCLY) most recently reported earnings on April 29, 2024 for Q2 FY2024, posting EPS of $-0.00 (in line with the analyst consensus of —). The next LVCLY earnings date is expected around September 1, 2026.

Each quarter, investors track LVCLY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LVCLY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LVCLY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LVCLY earnings · 4 questions

Living Cell Technologies Limited's next earnings report is expected around September 1, 2026. LVCLY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LVCLY historically reports after market close (AMC).

LVCLY earnings datewhen is LVCLY earningsLVCLY next earnings datewhen does LVCLY report earningsLVCLY earnings calendar

▸ Source: FMP · Living Cell Technologies Limited SEC filings · US GAAP · Living Cell Technologies Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026